Ghost Tree Capital, LLC Aclaris Therapeutics, Inc. Transaction History

Ghost Tree Capital, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$7.07 - $17.95 $3 Million - $7.63 Million	425,000 New	425,000 $3.44 Million
Q2 2022 Aug 15, 2022	SELL	$10.16 - $17.08 $1.27 Million - $2.14 Million	-125,000 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$9.74 - $17.92 $1.95 Million - $3.58 Million	-200,000 Reduced 61.54%	125,000 $2.16 Million
Q4 2021 Feb 16, 2022	BUY	$12.27 - $18.49 $613,500 - $924,499	50,000 Added 18.18%	325,000 $4.73 Million
Q3 2021 Nov 15, 2021	BUY	$13.38 - $18.8 $334,500 - $470,000	25,000 Added 10.0%	275,000 $4.95 Million
Q2 2021 Aug 11, 2021	SELL	$17.08 - $29.6 $5.98 Million - $10.4 Million	-350,000 Reduced 58.33%	250,000 $4.39 Million
Q1 2021 May 14, 2021	SELL	$5.86 - $27.73 $293,000 - $1.39 Million	-50,000 Reduced 7.69%	600,000 $15.1 Million
Q4 2020 Feb 16, 2021	BUY	$2.65 - $7.61 $1.72 Million - $4.95 Million	650,000 New	650,000 $4.21 Million

50.7M

30.6K

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $193M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ghost Tree Capital, LLC with notifications on news.